Cargando…

Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

BACKGROUND: Polypharmacy is defined as the prescription of at least 5 different medicines for therapeutic or prophylactic effect and is a serious issue among elderly patients, who are frequently affected by multi-morbidity. Deprescribing is one of the proposed approaches to reduce the number of admi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crisafulli, Salvatore, Luxi, Nicoletta, Coppini, Raffaele, Capuano, Annalisa, Scavone, Cristina, Zinzi, Alessia, Vecchi, Simona, Onder, Graziano, Sultana, Janet, Trifirò, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527765/ https://www.ncbi.nlm.nih.gov/pubmed/34666689 http://dx.doi.org/10.1186/s12875-021-01557-y

Ejemplares similares

Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
por: Crisafulli, Salvatore, et al.
Publicado: (2020)

Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy
por: Ferrajolo, Carmen, et al.
Publicado: (2019)

Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia
por: Gembillo, Guido, et al.
Publicado: (2021)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020)

Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
por: Sultana, Janet, et al.
Publicado: (2020)

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
por: Luxi, Nicoletta, et al.
Publicado: (2021)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
por: Rafaniello, Concetta, et al.
Publicado: (2020)

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
por: Rafaniello, Concetta, et al.
Publicado: (2021)

Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
por: Crisafulli, Salvatore, et al.
Publicado: (2023)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses
por: Sultana, Janet, et al.
Publicado: (2017)

Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases
por: Crisafulli, Salvatore, et al.
Publicado: (2022)

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
por: Liguori, Valerio, et al.
Publicado: (2023)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
por: Trifirò, Gianluca, et al.
Publicado: (2020)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
por: Zinzi, Alessia, et al.
Publicado: (2023)

Clinical and economic burden of adverse drug reactions
por: Sultana, Janet, et al.
Publicado: (2013)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
por: Crisafulli, Salvatore, et al.
Publicado: (2020)

Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence
por: Crisafulli, Salvatore, et al.
Publicado: (2023)

NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
por: Capuano, Annalisa, et al.
Publicado: (2020)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy
por: Ciccimarra, Francesco, et al.
Publicado: (2023)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023)

Italian Immunization Goals: A Political or Scientific Heated Debate?
por: Scavone, Cristina, et al.
Publicado: (2018)

Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust
por: Kibongani Volet, Annie, et al.
Publicado: (2022)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Deprescribing: Fashion Accessory or Fig Leaf?
por: Zermansky, Arnold G.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ssasihpqsbmplemg422d89mjou